The Conversation
Edition:
Available editions
Africa
Job Board
Become an author
Sign up as a reader
Sign in
The Conversation
Academic rigour, journalistic flair
Arts + Culture
Business + Economy
Education
Environment + Energy
Health + Medicine
Politics + Society
Science + Technology
In French
Curing blindness with stem cells – here’s the latest science
February 28, 2018 5.08pm SAST
Vic29
Author
Rachel Gater
PhD Candidate, Keele University
Disclosure statement
Rachel Gater receives PhD studentship funding from Keele University ACORN fund and Faculty of Medicine & Health Sciences.
Partners
Keele University
Keele University provides funding as a member of The Conversation UK.
The Conversation is funded by Barclays Africa and seven universities, including the Cape Peninsula University of Technology, Rhodes University and the Universities of Cape Town, Johannesburg, Kwa-Zulu Natal, Pretoria, and South Africa. It is hosted by the Universities of the Witwatersrand and Western Cape, the African Population and Health Research Centre and the Nigerian Academy of Science. The Bill & Melinda Gates Foundation is a Strategic Partner. more
Republish this article
Republish
Republish our articles for free, online or in print, under Creative Commons licence.
Email
Twitter10
Facebook67
LinkedIn
Print
In 2006, Nature published a paper describing how stem cells could be used to restore sight in blind mice. This study, and similar subsequent studies, created a lot of excitement about the potential of stem cells to cure blindness in humans. Fast forward 12 years and we still don’t seem to be quite there – one notable human clinical trial in Japan was stopped in 2015 due to a risk of tumour development in a patient’s eye. So are we any closer to using stem cell therapies to treat blindness, or will we always be “ten years away”?
Eye spy
The retina is an important tissue at the back of the eye that senses light and sends visual information to the brain. Eye diseases such as glaucoma and macular degeneration are characterised by damage to retina cells, which can eventually lead to vision loss and blindness. Scientists hope to find a way to replace or preserve damaged retina cells in order to treat these eye diseases.
Stem cells might be useful for this because they can be triggered to turn into any type of cell. In 2010 scientists successfully guided stem cells into becoming retina cells in a laboratory. It is hoped that these cells could later be delivered into the diseased eye to replace or preserve damaged retina cells.
Although scientists have previously had success isolating and maintaining retina stem cells in the laboratory, there is still more work to do before these cells can be routinely delivered to patients for treatment. The first big challenge is figuring out how treatments can safely be delivered into the patient’s eye in the right location. The eye is such a small and fragile organ that injection needles and surgery may cause even greater damage to the eye.
Once a delivery method has been established, the next challenge is deciding how to get the stem cells to communicate with existing retina cells and function properly inside the eye. Getting this to happen is not easy and there are risks that the stem cells may not function correctly and could cause problems, such as inflammation and tumour development, inside the eye.
In addition to these hurdles, scientists also need to overcome the challenge of immune rejection. In the same way that the body might reject a new heart after transplant surgery, stem cells might also get rejected by the body. Stem cell therapies developed from a patient’s own cells have a reduced chance of immune rejection, though they may be more expensive and time consuming to develop. For stem cell therapies developed from donor cells, drugs such as immunosuppressants are likely to be needed.
Tefi/Shutterstock
Building miniature scaffolds
In order to overcome these challenges, one approach scientists are investigating is the use of biomaterials. Biomaterials are typically materials that have been modified to interact with biological systems. It is hoped that these materials could be used to improve the delivery of stem cell therapy, as well as the integration with existing cells once inside the eye.
An example of this is the use of biomaterial scaffolds. As the name suggests, these are scaffolding-like structures that cells can hold onto in order to improve their chances of growth and survival. Scientists have already successfully developed biomaterial scaffolds that closely resemble the environment of retina tissue.
Attaching the stem cells to these scaffolds before delivery into the eye may improve their chances of communicating with existing cells and functioning correctly once inside. This technique has been successful in studies with mice and some human clinical trials are already in progress.
Therefore despite the challenges, scientists continue to look for ways to treat debilitating eye diseases. The eye is an incredibly complex and fragile organ, which is why research in this area may take a bit longer than for other parts of the body.
There are still hurdles that need to be overcome, such as the delivery technique of stem cells, their integration with existing cells once inside the eye and the chance of immune rejection. However, ongoing research into the use of biomaterials to improve stem cell integration has had promising results and may overcome some of these initial challenges.
So with continued support of this field of research we can be hopeful that, if the latest clinical trials run successfully, a cure for blindness using stem cells could finally be possible within the next ten years.
Stem cells
eye disease
Blindness
Eye
Glaucoma
macular degeneration
Tweet
Share
Get newsletter
You might also like
CHIP – an important risk factor for heart attack you’ve probably never heard of
Stem cells show promise – but they also have a darker side
How alcohol damages stem cells and increases cancer risk – new research
First working eggs made from stem cells points to fertility breakthrough
Sign in to comment
1 Comment
Oldest Newest
Ken Seidel
logged in via Google
Great article. Sure hope Science can progress faster then my AMD is progressing. I’d like Science to be the winner!
18 hours ago
Report
Most popular on The Conversation
China’s media struggles to overcome stereotypes of Africa
Africa’s rich fossil finds should get the air time they deserve
From slavery to colonialism and school rules: a history of myths about black hair
Africa waves some leaders goodbye: but is the democratic deficit any narrower?
After Somali piracy, is sailing the Western Indian Ocean safe again?
How we pinned down what attracts mosquitos that carry dengue fever
The paradox of tolerance is put to the test in South Africa
Thinking of taking a walk everyday? Six reasons why it’s good for you
White men’s privilege in emerging economies isn’t measured. It should be
How Western Cape farmers are being hit by the drought
Expert Database
Find experts with knowledge in:*
Want to write?
Write an article and join a growing community of more than 63,400 academics and researchers from 2,272 institutions.
Register now
The Conversation
Community
Community standards
Republishing guidelines
Research and Expert Database
Analytics
Job Board
Our feeds
Company
Who we are
Our charter
Our team
Partners and funders
Contributing institutions
Resource for media
Contact us
Stay informed and subscribe to our free daily newsletter and get the latest analysis and commentary directly in your inbox.
Email address
Follow us on social media
Privacy policy Terms and conditions Corrections
Copyright © 2010–2018, The Conversation Africa, Inc.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment